-+ 0.00%
-+ 0.00%
-+ 0.00%

Wave Life Sciences CSO Erik Ingelsson files initial beneficial ownership statement

PUBT·04/18/2026 01:00:39
Listen to the news
Wave Life Sciences CSO Erik Ingelsson files initial beneficial ownership statement
  • Wave Life Sciences Chief Scientific Officer Erik Ingelsson filed an initial Form 3 disclosing 87,864 ordinary shares.
  • Ingelsson also reported share options covering 823,750 ordinary shares, with exercise prices up to $12.75.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wave Life Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-162126), on April 17, 2026, and is solely responsible for the information contained therein.